Annexon, Inc. (ANNX) Financial Statements (2023 and earlier)

Company Profile

Business Address 1400 SIERRA POINT PARKWAY
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:242,700242,700351,200
Cash and cash equivalents140,02074,843268,565
Short-term investments102,637167,87282,641
Other undisclosed cash, cash equivalents, and short-term investments43(15)(6)
Prepaid expense1,4331,5131,763
Other current assets2034633
Other undisclosed current assets3,7623,0171,045
Total current assets:248,098247,693354,011
Noncurrent Assets
Operating lease, right-of-use asset19,12820,333 
Property, plant and equipment16,83817,8481,935
Restricted cash and investments1,0321,166 
Total noncurrent assets:36,99839,3471,935
TOTAL ASSETS:285,096287,040355,946
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,86420,40310,231
Accounts payable7,41611,1533,734
Accrued liabilities13,4489,2506,497
Deferred rent credit   391
Other liabilities180139 
Other undisclosed current liabilities1,3161,202 
Total current liabilities:22,36021,74410,622
Noncurrent Liabilities
Long-term debt and lease obligation:  33,387 
Liabilities, other than long-term debt31,542 1,046
Deferred rent credit   1,046
Operating lease, liability31,54233,387 
Other undisclosed noncurrent liabilities  (33,387) 
Total noncurrent liabilities:31,54233,3871,046
Total liabilities:53,90255,13111,668
Equity
Equity, attributable to parent231,194231,909344,278
Common stock483938
Additional paid in capital669,780528,365510,309
Accumulated other comprehensive loss(372)(180)(77)
Accumulated deficit(438,262)(296,315)(165,992)
Total equity:231,194231,909344,278
TOTAL LIABILITIES AND EQUITY:285,096287,040355,946

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues
(Sublease Income)
1,600100 
Gross profit:1,600100 
Operating expenses(145,599)(130,713)(63,469)
Other undisclosed operating loss(1,600)(100) 
Operating loss:(145,599)(130,713)(63,469)
Nonoperating income
(Other Nonoperating income)
   57
Loss from continuing operations before equity method investments, income taxes:(145,599)(130,713)(63,412)
Other undisclosed income from continuing operations before income taxes287,546390 
Income (loss) from continuing operations:141,947(130,323)(63,412)
Loss before gain (loss) on sale of properties:(130,323)(63,412)
Net income (loss):141,947(130,323)(63,412)
Other undisclosed net loss attributable to parent(283,894)  
Net loss attributable to parent:(141,947)(130,323)(63,412)
Preferred stock dividends and other adjustments   (705)
Other undisclosed net loss available to common stockholders, basic   (6,219)
Net loss available to common stockholders, diluted:(141,947)(130,323)(70,336)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net income (loss):141,947(130,323)(63,412)
Comprehensive income (loss):141,947(130,323)(63,412)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(284,086)(103)3
Comprehensive loss, net of tax, attributable to parent:(142,139)(130,426)(63,409)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: